Page 7 - Diabetes
Biocon Biologics, Viatris launch interchangeable insulin biosimilar for US
These injections will help control high blood sugar in adult and pediatric patients with type-1 diabetes and adults with type-2
IMA urges Covid vax, including booster dose if needed, for all diabetics
Noticing their vulnerabilities, IMA on Sunday demanded Covid-19 vaccination for all diabetes patients, including a third dose, if needed. The IMA on Sunday launched a campaign for early detection and mitigation of diabetes complications with organising of walkathon, marathon, screening camps, and a social media drive. The campaign also included research paper promotion among young doctors and an "intense" personal intervention at hospitals. The campaign, launched on the occasion of world Diabetes Day, will run for 10 days and will aim to reach one billion people, the Indian Medical Association (IMA) said in a statement. As part of the campaign, the IMA has joined hands with the association of Physicians of India, RSSDI, Endocrine Society, and many other niche organisations. As per the data from the 10th Edition of the IDF Diabetes Atlas, diabetes caused 6.7 million deaths in 2021, with 537 million adults (aged 20 to 79 years) around the world currently living with the condition.
Post-Covid fatigue is most prevalent in diabetes patients: Study
People with Type-2 diabetes who also suffered Covid-19 are more likely to experience severe fatigue than those who did not have the infectious disease, according to a new study released on Thursday
Germany's Boehringer, Indian pharma in legal battle over diabetes drug
The German drug maker has obtained interim injunctions against MSN Labs and Dr Reddy's Lab
NPPA fixes price caps for 12 anti-diabetic medicines
These include glimepiride tablet of strength 1 mg, with ceiling price at Rs 3.6 per tablet, while that for 2 mg is Rs 5.72 per tablet
Study finds why people with diabetes develop severe Covid-19
A recent study by a team of international clinical researchers reveals the mechanism behind cytokine storm during coronavirus infection.
Startup Sugar.fit, which aims to reverse diabetes, to raise $10 million
Health and fitness firm Cure.fit and two others to invest the funds in a deal likely to by September
Wockhardt's growth tonic: Covid vaccines add a third prong to biz strategy
In India, Wockhardt aims to make 2 billion doses of Covid-19 vaccines within the next one or two years but has not disclosed the identity of the tie-ups
Ethnic diversity helps identify more diabetes-related genomic regions
By including multi-ethnic participants, a large-scale genetic study by the University of Exeter has identified more regions of the genome linked to type-2 diabetes-related traits
Two pandemics clash as doctors find that coronavirus spurs diabetes
When Ziyad Al-Aly's research team told him how often diabetes appeared to strike Covid-19 survivors, he thought the data must be wrong, so he asked his five colleagues to crunch the numbers again.
Big Tech uses AI to arrest blindness among India's burgeoning diabetics
Diabetic retinopathy is a leading cause of blindness and vision loss in adults and tech giants such as Intel and Google are building AI-based innovations to address such problems
Covid vaccination voluntary, those already infected can also get the jab
A detailed FAQ released by health ministry has also addressed issues on suitability in co-morbid cases, delivery procedure among other things
AstraZeneca aims to impact 10 mn diabetics by 2023, starts awareness drive
India will have 115 mn diabetics by 2030. Forty-four per cent of patients hospitalised for heart failure have type-2 diabetes
Diabetic eye disease associated with five-fold risk of severe coronavirus
People with diabetes and eye disease have a five-fold increased risk of requiring intubation when hospitalised with Covid-19, suggest the findings of a new study
Ahead of World Diabetes Day, experts call for action to address epidemic
Ahead of World Diabetes Day, a new report has called for action to close the gap in diabetes prevention and care
Sun Pharma arm recalls one lot of diabetes drug Riomet ER oral in US
Sun Pharma has said it is voluntarily recalling one lot of Riomet ER oral suspension in the US market, due to the presence of a probable human carcinogen above the acceptable daily intake limit.
Lupin recalls diabetes treatment drug Metformin Hydrochloride in US
Drug major Lupin Ltd on Wednesday said it is voluntarily recalling its diabetes treatment drug Metformin Hydrochloride extended-release tablets in the US market
Cipla, Boehringer Ingelheim to co-sell 3 oral anti-diabetic drugs in India
Pharma major Cipla and drug firm Boehringer Ingelheim India on Monday announced partnership to co-market three new oral anti-diabetic drugs in the country. The companies have entered into a partnership for co-marketing three new oral anti-diabetics drugs --- Oboravo (Empagliflozin),Oboravo Met (Empagliflozin+Metformin) and Tiptengio (Empagliflozin+Linagliptin) in India, Cipla and Boehringer Ingelheim India Pvt Ltd said in a statement. As per the International Diabetes Federation, India is home to 7.7 crore diabetic adults aged between 20-79 years, ranking second behind China, and is poised to reach 13.42 crore patients by 2045, it added. "Diabetes continues to be a focus area for Cipla and with a strategic partnership with Boehringer Ingelheim coupled with our strong brand building, patient access and reach capabilities, we will be at the forefront of providing holistic diabetes care," Cipla India Business Executive VP & CEO Nikhil Chopra said. In a similar vein, Boehringer ...
Covid-19 and diabetes: Different risks for people with type 1 and type 2
It is still unclear whether people with diabetes are more likely to catch the virus
Shramik trains: Rlys appeal to people with comorbidities to avoid travel
At least nine passengers were reported dead on May 27 over a span of 48 hours on board the migrant trains, with the railways stating that all of them had health conditions.
